One possible reason for this discrepancy could be that PSMA expression in apical membranes—typical for prostate carcinoma cells—is connected with a higher tracer uptake on PET imaging than the level of PSMA expression in cytoplasm, which is often observed in nonprostatic disease [44]. Here, FOLH1 is linked to prostate carcinoma.